Delivery Order SPE2DB20D1109-SPE2DB25FN35S
Award Date
1/6/25
Potential Completion Date
1/7/25
Potential Value
$3.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,038.52, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4566449785 CEFEPIME-DEXTROSE 2 GM/50 MLS, a medical product, with a completion date of November 18, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type, and it is not designated with a Set-Aside.
Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,287.99 firm fixed-price delivery order is for the supply of Cefepime-Dextrose 2 GM/50 MLS, a pharmaceutical product. The contract has an ultimate completion date of January 19, 2023.
AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of CEFEPIME-DEXTROSE 2 GM/50 MLS. The $2,668.35 firm-fixed-price delivery order contract has a period of performance through July 30, 2024. It is not designated as a set-aside contract. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of 4565643182 CEFEPIME-DEXTROSE 2 GM/50 MLS, a pharmaceutical product. The contract has a firm fixed price of $5,387.42 and a completion date of September 3, 2024. This award is not associated with a set-aside program. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies...
This federal contract award, valued at $10,948.29, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order contract for the supply of CEFEPIME-DEXTROSE 2 GM/50 MLS, a medical product, with a completion date of January 9, 2025. The contract is a firm fixed-price arrangement and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,287.99 firm fixed-price delivery order is for the supply of 4559118428 - CEFEPIME-DEXTROSE 2 GM/50 MLS, a critical pharmaceutical product. There was no set-aside designation for this award.
This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,616.99 Firm Fixed Price Delivery Order contract is for the supply of 4566373440 CEFEPIME-DEXTROSE 2 GM/50 MLS, a medical product. The contract has an ultimate completion date of November 8, 2024 and was awarded on November 7, 2024. The award is not associated with a set-aside program. Amerisourcebergen holds a...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,564,107,064 units of the pharmaceutical product CEFEPIME-DEXTROSE 2 GM/50 MLS. This $23,944.67 award has an ultimate completion date of March 29, 2024 and is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 awarded solely to Amerisourcebergen Drug Corp by DLA. The IDC serves as the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The contract is for the delivery of Cefepime-Dextrose 2 gram/50 milliliter pharmaceutical products, with a ceiling value of $3,443.69 and a performance period through April 5, 2024. This award is a firm fixed price delivery order under a larger indefinite delivery contract...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the supply of 4,564,792,363 units of the pharmaceutical product CEFEPIME-DEXTROSE 2 GM/50 MLS. The Delivery Order has a ceiling value of $2,808.83 and a completion date of June 4, 2024. The contract is a Firm Fixed Price arrangement without any set-aside designation.
Amerisourcebergen Drug Corp is a major supplier of pharmaceuticals and medical...